| Ms Rebecca Fletcher, CRNA | |
|
1029 Medical Center Cir, Mayfield, KY 42066-1189 | |
| (270) 251-4100 | |
| Not Available |
| Full Name | Ms Rebecca Fletcher |
|---|---|
| Gender | Female |
| Speciality | Nurse Anesthetist, Certified Registered |
| Location | 1029 Medical Center Cir, Mayfield, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295864262 | NPI | - | NPPES |
| 000000355014 | Other | KY | KY BCBS IND |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 1045966 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Rebecca Fletcher, CRNA 6111 Harris Rd, Paducah, KY 42001-9629 Ph: (573) 686-5550 | Ms Rebecca Fletcher, CRNA 1029 Medical Center Cir, Mayfield, KY 42066-1189 Ph: (270) 251-4100 |
News Archive
Trius Therapeutics, Inc. announced today that it has reached agreement with the United States Food and Drug Administration (FDA), under the Special Protocol Assessment (SPA) process, on the design of its planned Phase 3 study for the oral dosage form of torezolid phosphate for treatment of acute bacterial skin and skin structure infections (ABSSSI).
"CRN is pleased that the Senate today passed S. 510, FDA Food Safety Modernization Act (FDAFSMA). CRN and its member companies support this bill because of the added enforcement tools it would provide to FDA and the extra protections it would provide for consumers.
A study published in the current issue of Psychotherapy and Psychosomatics provides new insights in the different rates of post-traumatic stress disorder that are found in studies performed in different countries.
The New York Times examines the WHO's role as a "clearinghouse" for getting the H1N1 (swine flu) vaccine to lower income nations. Though H1N1 has died down in North America and many wealthier nations "are trying to get rid of their [vaccine] surpluses," the virus continues to circulate in regions of North Africa, Central Asia and Eastern Europe, according to the newspaper.
Abraxis BioScience, Inc., a fully integrated biotechnology company, previously announced it will be presenting more than 30 studies, including new clinical data evaluating the use of nanoparticle albumin bound driven chemotherapy, nab-paclitaxel (ABRAXANE for Injectable suspension; paclitaxel protein albumin-bound particles for injectable suspension) for the treatment of pancreatic cancer at the 46th Annual Meeting of the American Society of Clinical Oncology in Chicago.
› Verified 3 days ago
Amanda Massey, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1099 Medical Center Cir, Mayfield, KY 42066 Phone: 270-251-4100 | |
Teena Patty, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1549 Bellemeade Dr, Mayfield, KY 42066 Phone: 270-251-0079 Fax: 270-251-0079 | |
Mary Houser, Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 1099 Medical Center Cir, Mayfield, KY 42066 Phone: 270-251-4100 | |
Linda G Harris, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1029 Medical Dr, Mayfield, KY 42066 Phone: 270-748-6891 Fax: 270-554-8103 | |
Linda Riley, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1029 Medical Center Cir, Mayfield, KY 42066 Phone: 573-686-5550 |